XML 49 R37.htm IDEA: XBRL DOCUMENT v3.24.2.u1
EQUITY (Tables)
 6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of Warrants Outstanding and Exercisable The following table summarizes the status of warrants and related transactions:
Non-Derivative (Equity) Warrants
Derivative Liabilities Warrants
Total Number of WarrantsWeighted - Average Exercise Price
Balance as of January 1, 2024
49,068,63637,862,92286,931,558$1.12 
Granted (1)
2,050,000 — 2,050,000 $0.97 
Cancelled/forfeited/expired(416,667)— (416,667)$1.56 
Balance as of June 30, 2024
50,701,96937,862,92288,564,891$1.12 
Exercisable as of June 30, 2024
49,141,96937,862,92287,004,891$1.12 
(1)In February 2024, there were 1,800,000 warrants issued in connection with the Debt Exchange. Refer to Note 8 - Debt for more information.
Schedule of Share-Based Payment Award, Warrants, Valuation Assumptions The following assumptions were used for the calculation at date of issuance:
Weighted average stock price$0.93
Weighted average expected stock price volatility76.5%
Expected annual dividend yield0%
Weighted average expected life of warrants
3.1 years
Weighted average risk-free annual interest rate4.1%
Weighted average grant date fair value$0.48
Schedule of Stock Options Outstanding The following table summarizes the status of stock options and related transactions:
Number of Stock OptionsWeighted-Average Per Share Exercise Price
Issued and Outstanding as of January 1, 202427,653,184 $1.40 
Granted1,905,000 $0.70 
Exercised
(11,666)$0.60 
Cancelled/forfeited/expired(2,936,498)$1.70 
Issued and Outstanding as of June 30, 202426,610,020 $1.31 
Exercisable as of June 30, 202416,531,064 $1.61 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions The following assumptions were used for the calculation at date of grant:
Six Months Ended June 30,
20242023
Weighted average stock price$0.70$0.51
Weighted average expected stock price volatility77.9%76.9%
Expected annual dividend yield0%0%
Weighted average expected life5.1 years6.0 years
Weighted average risk-free annual interest rate4.3%3.6%
Weighted average grant date fair value$0.46$0.34
Schedule of Nonvested Restricted Stock Shares Activity The following table summarizes the status of restricted stock and related transactions:
Number of Restricted Subordinate Voting Shares
Unvested restricted stock as of January 1, 20241,861
Unvested restricted stock as of June 30, 20241,861
Schedule of Components of Share-based Compensation Expense
The components of share-based compensation expense are as follows:
Three Months Ended June 30,Six Months Ended June 30,
2024202320242023
Stock options$594 $1,862 $1,949 $3,458 
Restricted stock1 93 2 293 
Warrants(248)408 (80)923 
Total share-based compensation expense$347 $2,363 $1,871 $4,674